540468 — KMS Medisurgi Income Statement
0.000.00%
- IN₹417.45m
- IN₹421.91m
- IN₹139.39m
Annual income statement for KMS Medisurgi, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 75.1 | 103 | 110 | 139 | 139 |
Cost of Revenue | |||||
Gross Profit | 17.4 | 25.3 | 31.1 | 31.4 | 33.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 73.4 | 100 | 104 | 134 | 133 |
Operating Profit | 1.74 | 2.73 | 6.43 | 5.32 | 6.64 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.37 | 2.85 | 6.58 | 6.04 | 6.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.23 | 2.15 | 5.73 | 4.54 | 4.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.23 | 2.15 | 5.73 | 4.54 | 4.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.23 | 2.15 | 5.73 | 4.54 | 4.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.372 | 0.652 | 1.74 | 1.38 | 1.33 |
Dividends per Share |